Prognostic significance of CD40 expression in malignant lymphoma developing in rheumatoid arthritis

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 12, 2005, Pages 797-802

  Sasaki, Toru ^a   Hoshida, Yoshihiko ^a   Xu, Jian Xian ^a   Tomita, Yasuhiko ^a   Sakane Ishikawa, Emi ^a   Fujita, Shigeki ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD40; Lymphoma; Methotrexate; Prognosis; Rheumatoid arthritis

Indexed keywords

CD40 ANTIGEN; MESSENGER RNA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL LITERATURE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

AGED; ANTIGENS, CD40; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SYNOVIAL FLUID; TUMOR MARKERS, BIOLOGICAL;

EID: 27744581178     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0034-z     Document Type: Article

References (20)

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511
2. Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L (1998) Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 317:180-181
3. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922
4. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 17:1244-1253
5. Cox DR (1972) Regression models and life tables. J Roy Stat Soc (B) 34:187-220
6. French RR, Chan HT, Tutt AL, Glennie MJ (1999) CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat Med 5:548-553
7. Harney S, Wordsworth BP (2002) Genetic epidemiology of rheumatoid arthritis. Tissue Antigens 60:465-473
8. Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6:986-994
9. Holland PM, Abramson RD, Watson R, Gelfand DH (1991) Detection of specific polymerase chain reaction product by utilizing the 5-3 exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88:7276-7280
10. Hoshida Y, Tomita Y, Zhiming D, Yamauchi A, Nakatsuka S, Kurasono Y, Arima Y, Tsudo M, Shintaku M, Aozasa K (2004) Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 108:443-449
11. Isler P, Vey E, Zhang JH, Dayer JM (1993) Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69. Eur Cytokine Netw 4:15-23
12. Jaffe ES, Harris NL, Stein H, Vardinum JW eds (2001) Pathology and genetics, tumours of haematopoietic and lymphoid tissues, World Health Organization Classification of Tumours. IARC Press, Lyon
13. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Statist Assoc 53:457-481
14. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434-438
15. Li JM, Nichols MA, Chandrasekharan S, Xiong Y, Wang XF (1995) Contact-dependent stimulation of monocytic cells and neutrophils by stimulated human T-cell clones. Immunology 84:571-576
16. Linderoth J, Jerkeman M, Cavallin-Stahl E, Kvaloy S, Torlakovic E, Nordic Lymphoma Group Study (2003) Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroup of diffuse large B cell lymphoma: a Nordic lymphoma study. Clin Cancer Res 9:727-728
17. Liu MF, Chao SC, Wang CR, Lei HY (2000) Expression of CD40 and CD40 ligand among cell population within rheumatoid synovial compartment. Autoimmunity 34:107-113
18. Szocinski JL, Khaled AR, Hixon J, Halverson D, Funakoshi S, Fanslow WC, Boyd A, Taub DD, Durum SK, Siegall CB, Longo DL, Murphy WJ (2002) Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax. Blood 100:217-223
19. Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M, Aozasa K (2003) Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 21:447-452
20. Weiss LM, Chen YY, Liu XF, Shibata D (1991) Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259-1265